expert review of clinical immunology

the malaysian journal of pathology

[1] Nanoparticle-based immunotherapy: state of the art and future perspectives.

[2] Properties of Coronavirus and SARS-CoV-2.

[3] integrated process for capture and purification of virus-like particles: enhancing process performance by cross-flow filtration

[4] intranasal immunization with influenza virus-like particles containing membrane-anchored cholera toxin b or ricin toxin b enhances adaptive immune responses and protection against an antigenically distinct virus

[5] preclinical development and production of virus-like particles as vaccine candidates for hepatitis c

[6] harnessing nanoparticles for immunomodulation and vaccines

[7] Mesoscale model of the assembly and cross-linking of HPV virus-like particles.

[8] Formation of Virus-Like Particles of the Dengue Virus Serotype 2 Expressed in Silkworm Larvae.

[9] Synthetic virus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection

[10] Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice

[11] Recent Advances in the Use of Plant Virus-Like Particles as Vaccines.

[12] An electron microscopic study of natural scrapie sheep brain: Further observations on virus-like particles and paramyxovirus-like tubules

[13] integrated process for capture and purification of virus-like particles: enhancing process performance by cross-flow filtration

[14] intranasal immunization with influenza virus-like particles containing membrane-anchored cholera toxin b or ricin toxin b enhances adaptive immune responses and protection against an antigenically distinct virus

[15] preclinical development and production of virus-like particles as vaccine candidates for hepatitis c